These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9650212

  • 1. [Clinical relevance of I-123/I-131-MIBG scintigraphy in intestinal carcinoid tumors].
    van de Flierdt E, Frank T, Laubenbacher C, Fink U, Bauer R, Langhammer HR, Pabst HW.
    Nuklearmedizin; 1998 Jun; 37(4):129-33. PubMed ID: 9650212
    [Abstract] [Full Text] [Related]

  • 2. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
    Bihl H, Sautter-Bihl ML, Wilhelm KR, Kimmig B.
    Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Contribution of 131I MIBG scintigraphy in the diagnosis of carcinoid tumors of the digestive tract. Experience of 14 cases].
    Siproudhis L, Lescouarc'h J, Bretagne JF, Bourguet P, Raoul JL, Etienne PL, Herry JY, Gosselin M.
    Gastroenterol Clin Biol; 1991 Dec; 15(11):789-93. PubMed ID: 1769467
    [Abstract] [Full Text] [Related]

  • 7. Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.
    Taal BG, Hoefnagel C, Boot H, Valdés Olmos R, Rutgers M.
    Ann Oncol; 2000 Nov; 11(11):1437-43. PubMed ID: 11142484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
    Lastoria S, Maurea S, Vergara E, Acampa W, Varrella P, Klain M, Muto P, Bernardy JD, Salvatore M.
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors.
    Sywak MS, Pasieka JL, McEwan A, Kline G, Rorstad O.
    World J Surg; 2004 Nov; 28(11):1157-62. PubMed ID: 15490060
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
    Safford SD, Coleman RE, Gockerman JP, Moore J, Feldman J, Onaitis MW, Tyler DS, Olson JA.
    Cancer; 2004 Nov 01; 101(9):1987-93. PubMed ID: 15455358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.